Time of post-procedural MRI, days | 5 (4-7) | 5 (4-7) | 5 (4-6) | 0.195 |
Patients with new lesions | 126 (79.7) | 69 (81.2) | 57 (78.1) | 0.629 |
Lesion location (patients) | | | | 0.107 |
Left hemisphere lesions | 20 (15.9) | 11 (15.9) | 9 (15.8) | |
Right hemisphere lesions | 22 (17.5) | 7 (10.1) | 15 (26.3) | |
Bihemispheric lesions | 84 (66.7) | 51 (73.9) | 33 (57.9) | |
Total number of lesions | 718 | 379 | 339 | |
Number of lesions per patient | 4.54±5.26 | 4.46±4.73 | 4.64±5.84 | 0.826 |
ACA lesions (n=97) | 0.61±1.13 | 0.58±1.02 | 0.66±1.25 | 0.654 |
Total volume ACA lesions, mm3 | 45.13±102.68 | 38.59±77.02 | 52.74±126.33 | 0.389 |
Total volume/lesions in ACA, mm3 | 24.75±51.58 | 24.71±52.41 | 24.79±50.97 | 0.991 |
ACA/MCA lesions* (n=98) | 0.62±1.25 | 0.73±1.25 | 0.49±1.26 | 0.239 |
Total volume ACA/MCA lesions, mm3 | 50.06±112.45 | 63.06±126.90 | 34.93±91.40 | 0.109 |
Total volume/lesions in ACA/MCA, mm3 | 25.05±48.59 | 31.89±55.78 | 17.08±37.39 | 0.049 |
MCA lesions (n=218) | 1.38±2.12 | 1.51±2.07 | 1.23±2.18 | 0.422 |
Total volume MCA lesions, mm3 | 124.43±246.70 | 147.41±262.18 | 97.67±226.20 | 0.207 |
Total volume/lesions in MCA, mm3 | 44.93±63.78 | 54.54±74.72 | 33.75±46.03 | 0.034 |
MCA/PCA lesions* (n=20) | 0.13±0.49 | 0.12±0.52 | 0.14±0.45 | 0.805 |
Total volume MCA/PCA lesions, mm3 | 8.54±34.06 | 8.35±35.52 | 8.77±32.53 | 0.940 |
Total volume/lesions in MCA/PCA, mm3 | 6.00±23.97 | 5.91±26.75 | 6.10±20.45 | 0.962 |
PCA lesions (n=143) | 0.90±1.72 | 0.69±1.53 | 1.14±1.90 | 0.112 |
Total volume PCA lesions, mm3 | 175.00±1,232.21 | 70.71±262.21 | 296.44±1,789.64 | 0.252 |
Total volume/lesions in PCA, mm3 | 43.42±160.58 | 28.43±53.78 | 60.87±228.65 | 0.207 |
VA/BA lesions* (n=143) | 0.91±1.45 | 0.84±1.49 | 0.99±1.42 | 0.517 |
Total volume VA/BA lesions, mm3 | 180.70±638.99 | 164.00±600.66 | 200.14±684.61 | 0.724 |
Total volume/lesions in VA/BA, mm3 | 104.48±468.14 | 110.46±558.37 | 97.51±337.72 | 0.863 |